"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in Harvard Catalyst Profiles by year, and whether "Hemostatics" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 3 | 7 |
| 2002 | 1 | 3 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 6 | 1 | 7 |
| 2007 | 4 | 0 | 4 |
| 2008 | 7 | 1 | 8 |
| 2009 | 8 | 0 | 8 |
| 2010 | 4 | 1 | 5 |
| 2011 | 5 | 3 | 8 |
| 2012 | 4 | 1 | 5 |
| 2013 | 4 | 4 | 8 |
| 2014 | 6 | 2 | 8 |
| 2015 | 10 | 1 | 11 |
| 2016 | 3 | 4 | 7 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 1 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 6 | 2 | 8 |
| 2021 | 9 | 0 | 9 |
| 2022 | 7 | 1 | 8 |
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort. Circulation. 2022 Aug 02; 146(5):383-397.
-
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders. Thromb Haemost. 2022 Aug; 122(8):1304-1313.
-
Percutaneous delivery of self-propelling thrombin-containing powder increases survival from noncompressible truncal hemorrhage in a swine model of coagulopathy and hypothermia. J Trauma Acute Care Surg. 2022 08 01; 93(2S Suppl 1):S86-S93.
-
Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway. Front Immunol. 2022; 13:880829.
-
Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice. Blood Adv. 2022 04 26; 6(8):2628-2645.
-
Chitosan-based lifefoam improves survival in lethal noncompressible abdominal bleeding in swine. Surgery. 2022 07; 172(1):421-426.
-
Modulating Nanoparticle Size to Understand Factors Affecting Hemostatic Efficacy and Maximize Survival in a Lethal Inferior Vena Cava Injury Model. ACS Nano. 2022 02 22; 16(2):2494-2510.
-
Percutaneous delivery of self-propelling hemostatic powder for managing non-compressible abdominal hemorrhage: a proof-of-concept study in swine. Injury. 2022 May; 53(5):1603-1609.
-
Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States. J Manag Care Spec Pharm. 2022 Apr; 28(4):449-460.
-
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. Ann Thorac Surg. 2022 03; 113(3):1026-1035.